Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL
Back to RCKT Full portfolio

Position in RCKT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$243,401
+$243,401 QoQ
Shares Held
381,540
Ownership
0.348%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 180 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 19% Shared 0% None 81%

Common Shares in RCKT Over Time

Shares Held

Position Value (USD)

Derivatives in RCKT

reported options exposure · as of Jun 30, 2026
CallValue
$222,300
CallShares
65,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. RCKT ranks #305 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in RCKT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 RCKTW — 310,370
2026-06-30 $243,401 71,170
2026-06-30 $222,300 65,000
2026-03-31 $232,342 64,900
2026-03-31 $240,934 67,300
2025-12-31 RCKTW — 311,489
2025-12-31 $4,562,968 1,299,991
2025-12-31 $100,386 28,600
2025-09-30 $310,352 95,200
2025-09-30 $5,447,222 1,670,927
2025-09-30 $256,562 78,700
2025-06-30 $382,322 156,050
2025-06-30 $142,835 58,300
2025-06-30 $257,250 105,000
2025-03-31 $10,065,056 1,509,004
2025-03-31 $451,559 67,700
2025-03-31 $367,517 55,100
2024-12-31 $858,531 68,300
2024-12-31 $349,446 27,800
2024-12-31 $51,823,897 4,122,824
2024-09-30 RCKTW — 343,397
2024-09-30 $424,810 23,000
2024-09-30 $39,675,277 2,148,093
2024-09-30 $343,542 18,600
2024-06-30 RCKTW — 370,599
2024-06-30 $557,627 25,900
2024-06-30 $437,059 20,300
2024-06-30 $60,673,024 2,818,069
2024-03-31 $342,138 12,700
2024-03-31 $1,274,262 47,300
2024-03-31 $66,536,762 2,469,813
2023-12-31 RCKTW — 300,300
2023-12-31 $881,118 29,400
2023-12-31 $722,277 24,100
2023-12-31 $73,653,102 2,457,561
2023-09-30 RCKTW — 324,849
2023-09-30 $413,898 20,200
2023-09-30 $54,882,485 2,678,501
2023-09-30 $1,846,149 90,100
2023-06-30 RCKTW — 352,814
2023-06-30 $119,220 6,000
2023-06-30 $492,776 24,800
2023-06-30 $51,425,705 2,588,108
2023-03-31 RCKTW — 357,450
2023-03-31 $45,547,796 2,658,949
2023-03-31 $263,802 15,400
2023-03-31 $183,291 10,700
2022-12-31 $352,260 18,000
2022-12-31 $579,272 29,600
2022-12-31 $50,934,447 2,602,680

Report a Problem

Category
Description
Email (optional, for follow-up)